17i-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GP30: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    15 August 2022

    • curprev 02:4702:47, 15 August 2022‎ 187.21.138.9 talk‎ 580 bytes +580‎ Created page with "== Target Article == 17i-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GP30; A Vivacqua, D Bonofiglio, L Albanito, A Madeoae; 2006; doi_citing_unknown == Retraction == c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells ; Sarah Kraus Outhiriaradjou Benard Zvi Naor Rony Seger; 05..."
Retrieved from "https://wikicitingretracted.org/index.php?title=17i-Estradiol,_genistein,_and_4-hydroxytamoxifen_induce_the_proliferation_of_thyroid_cancer_cells_through_the_G_protein-coupled_receptor_GP30"